Brokers Offer Predictions for Kimberly-Clark FY2024 Earnings

Kimberly-Clark Co. (NYSE:KMB) – Research analysts at Zacks Research raised their FY2024 earnings per share (EPS) estimates for shares of Kimberly-Clark in a note issued to investors on Tuesday, November 12th. Zacks Research analyst R. Department now expects that the company will earn $7.27 per share for the year, up from their previous forecast of $7.21. The consensus estimate for Kimberly-Clark’s current full-year earnings is $7.27 per share. Zacks Research also issued estimates for Kimberly-Clark’s Q4 2024 earnings at $1.47 EPS, Q1 2025 earnings at $1.97 EPS, Q2 2025 earnings at $1.87 EPS, Q3 2025 earnings at $1.86 EPS, Q4 2025 earnings at $1.82 EPS, FY2025 earnings at $7.52 EPS, Q1 2026 earnings at $2.09 EPS, Q2 2026 earnings at $1.97 EPS, Q3 2026 earnings at $1.95 EPS and FY2026 earnings at $7.75 EPS.

Kimberly-Clark (NYSE:KMB) last posted its quarterly earnings data on Tuesday, October 22nd. The company reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.69 by $0.14. The company had revenue of $4.95 billion during the quarter, compared to analysts’ expectations of $5.06 billion. Kimberly-Clark had a return on equity of 198.59% and a net margin of 12.97%. Kimberly-Clark’s revenue for the quarter was down 3.5% compared to the same quarter last year. During the same period in the prior year, the business earned $1.74 earnings per share.

A number of other research analysts have also commented on KMB. JPMorgan Chase & Co. cut their price objective on shares of Kimberly-Clark from $142.00 to $140.00 and set an “underweight” rating for the company in a research report on Wednesday, October 23rd. Argus upgraded Kimberly-Clark to a “hold” rating in a research report on Friday, July 26th. Royal Bank of Canada reissued an “outperform” rating and set a $165.00 price objective on shares of Kimberly-Clark in a report on Wednesday, October 23rd. Deutsche Bank Aktiengesellschaft upped their target price on Kimberly-Clark from $146.00 to $147.00 and gave the company a “hold” rating in a research note on Tuesday, October 8th. Finally, Barclays lifted their price target on shares of Kimberly-Clark from $135.00 to $144.00 and gave the stock an “equal weight” rating in a research note on Friday, October 11th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, Kimberly-Clark currently has an average rating of “Hold” and an average target price of $149.93.

Kimberly-Clark Price Performance

NYSE:KMB opened at $134.08 on Thursday. The company has a debt-to-equity ratio of 4.77, a current ratio of 0.83 and a quick ratio of 0.55. The stock has a market cap of $44.71 billion, a P/E ratio of 17.39, a PEG ratio of 2.77 and a beta of 0.40. The company has a fifty day moving average price of $139.75 and a 200 day moving average price of $139.13. Kimberly-Clark has a one year low of $117.67 and a one year high of $149.30.

Institutional Trading of Kimberly-Clark

Several hedge funds have recently modified their holdings of the company. State Street Corp raised its position in Kimberly-Clark by 5.9% in the 3rd quarter. State Street Corp now owns 19,304,396 shares of the company’s stock valued at $2,768,367,000 after purchasing an additional 1,083,824 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of Kimberly-Clark by 19.1% in the first quarter. Price T Rowe Associates Inc. MD now owns 5,893,146 shares of the company’s stock valued at $762,279,000 after buying an additional 944,920 shares during the last quarter. Wulff Hansen & CO. lifted its position in Kimberly-Clark by 13,720.0% during the 2nd quarter. Wulff Hansen & CO. now owns 641,524 shares of the company’s stock worth $88,659,000 after buying an additional 636,882 shares in the last quarter. Marshall Wace LLP grew its holdings in Kimberly-Clark by 48.4% during the 2nd quarter. Marshall Wace LLP now owns 1,545,147 shares of the company’s stock worth $213,539,000 after acquiring an additional 503,839 shares during the last quarter. Finally, Ilex Capital Partners UK LLP increased its position in Kimberly-Clark by 140.0% in the 3rd quarter. Ilex Capital Partners UK LLP now owns 662,620 shares of the company’s stock valued at $94,278,000 after acquiring an additional 386,510 shares in the last quarter. Institutional investors and hedge funds own 76.29% of the company’s stock.

Kimberly-Clark Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 3rd. Shareholders of record on Friday, December 6th will be paid a dividend of $1.22 per share. The ex-dividend date is Friday, December 6th. This represents a $4.88 annualized dividend and a yield of 3.64%. Kimberly-Clark’s dividend payout ratio is 63.29%.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.